{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T16:06:08Z","timestamp":1790697968014,"version":"4.1.0"},"reference-count":54,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2013,2,1]],"date-time":"2013-02-01T00:00:00Z","timestamp":1359676800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,2,1]],"date-time":"2013-02-01T00:00:00Z","timestamp":1359676800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2013,11,28]],"date-time":"2013-11-28T00:00:00Z","timestamp":1385596800000},"content-version":"vor","delay-in-days":300,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/3.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinical-lymphoma-myeloma-leukemia.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Lymphoma Myeloma and Leukemia"],"published-print":{"date-parts":[[2013,2]]},"DOI":"10.1016\/j.clml.2012.09.002","type":"journal-article","created":{"date-parts":[[2012,10,27]],"date-time":"2012-10-27T07:45:20Z","timestamp":1351323920000},"page":"8-14","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":75,"title":["Intensive Induction Chemotherapy Followed by Early High-Dose Therapy and Hematopoietic Stem Cell Transplantation Results in Improved Outcome for Patients with Hepatosplenic T-Cell Lymphoma: A Single Institution Experience"],"prefix":"10.1016","volume":"13","author":[{"given":"Martin H.","family":"Voss","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew A.","family":"Lunning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jocelyn C.","family":"Maragulia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esperanza B.","family":"Papadopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jenna","family":"Goldberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew D.","family":"Zelenetz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven M.","family":"Horwitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clml.2012.09.002_bib1","doi-asserted-by":"crossref","first-page":"2213","DOI":"10.1182\/blood.V75.11.2213.2213","article-title":"Hepatosplenic T-cell lymphoma: sinusal\/sinusoidal localization of malignant cells expressing the T-cell receptor gamma delta","volume":"75","author":"Farcet","year":"1990","journal-title":"Blood"},{"key":"10.1016\/j.clml.2012.09.002_bib2","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1182\/blood.V84.5.1361.1361","article-title":"A revised European-American classification of lymphoid neoplasms: a proposal from the international lymphoma Study Group","volume":"84","author":"Harris","year":"1994","journal-title":"Blood"},{"issue":"Suppl 1","key":"10.1016\/j.clml.2012.09.002_bib3","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1093\/annonc\/11.suppl_1.S3","article-title":"Lymphoma classification\u2013from controversy to consensus: the R.E.A.L. and WHO Classification of lymphoid neoplasms","volume":"11","author":"Harris","year":"2000","journal-title":"Ann Oncol"},{"key":"10.1016\/j.clml.2012.09.002_bib4","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1309\/LRKX8CE7GVPCR1FT","article-title":"Hepatosplenic and other gammadelta T-cell lymphomas","volume":"127","author":"Vega","year":"2007","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.clml.2012.09.002_bib5","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S0037-1963(03)00137-9","article-title":"Gammadelta T-cell lymphomas","volume":"40","author":"Gaulard","year":"2003","journal-title":"Semin Hematol"},{"key":"10.1016\/j.clml.2012.09.002_bib6","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1023\/A:1008375931236","article-title":"The World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues","volume":"10","author":"Harris","year":"1999","journal-title":"Ann Oncol"},{"issue":"Suppl 1","key":"10.1016\/j.clml.2012.09.002_bib7","first-page":"S8","article-title":"World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues","volume":"111","author":"Jaffe","year":"1999","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.clml.2012.09.002_bib8","first-page":"617","article-title":"Expression of the alpha\/beta and gamma\/delta T-cell receptors in 57 cases of peripheral T-cell lymphomas","volume":"137","author":"Gaulard","year":"1990","journal-title":"Am J Pathol"},{"key":"10.1016\/j.clml.2012.09.002_bib9","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1097\/00000478-199506000-00013","article-title":"Hepatosplenic gamma delta T-cell lymphoma","volume":"19","author":"Wong","year":"1995","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.clml.2012.09.002_bib10","doi-asserted-by":"crossref","first-page":"3729","DOI":"10.3748\/wjg.v11.i24.3729","article-title":"Hepatosplenic gammadelta T-cell lymphoma","volume":"11","author":"Wei","year":"2005","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.clml.2012.09.002_bib11","doi-asserted-by":"crossref","first-page":"4265","DOI":"10.1182\/blood.V88.11.4265.bloodjournal88114265","article-title":"Hepatosplenic T-cell lymphoma: a distinct clinicopathologic entity of cytotoxic gamma delta T-cell origin","volume":"88","author":"Cooke","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.clml.2012.09.002_bib12","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1038\/sj.leu.2401784","article-title":"Hepatosplenic T cell lymphoma","volume":"14","author":"Weidmann","year":"2000","journal-title":"Leukemia"},{"key":"10.1016\/j.clml.2012.09.002_bib13","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1309\/YTTC-F55W-K9CP-EPX5","article-title":"Hepatosplenic gamma-delta T-cell lymphoma as a late-onset posttransplant lymphoproliferative disorder in renal transplant recipients","volume":"113","author":"Wu","year":"2000","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.clml.2012.09.002_bib14","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1309\/TC9U-FAV7-0QBW-6DFC","article-title":"Hepatosplenic gamma\/delta T-cell lymphoma in immunocompromised patients","volume":"116","author":"Khan","year":"2001","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.clml.2012.09.002_bib15","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1053\/hupa.2002.31301","article-title":"Hepatosplenic gammadelta-T-cell lymphoma with leukemic course after renal transplantation","volume":"33","author":"Steurer","year":"2002","journal-title":"Hum Pathol"},{"key":"10.1016\/j.clml.2012.09.002_bib16","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1111\/j.1440-1827.2006.02027.x","article-title":"Hepatosplenic gammadelta T-cell lymphoma following seven malaria infections","volume":"56","author":"Hassan","year":"2006","journal-title":"Pathol Int"},{"key":"10.1016\/j.clml.2012.09.002_bib17","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1097\/00000478-199707000-00006","article-title":"Hepatosplenic gamma\/delta T-cell lymphoma: a report of two cases in immunocompromised patients, associated with isochromosome 7q","volume":"21","author":"Fran\u00e7ois","year":"1997","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.clml.2012.09.002_bib18","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1053\/j.gastro.2003.10.047","article-title":"The safety profile of infliximab in patients with Crohn's disease: the Mayo Clinic experience in 500 patients","volume":"126","author":"Colombel","year":"2004","journal-title":"Gastroenterology"},{"key":"10.1016\/j.clml.2012.09.002_bib19","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/j.cgh.2008.03.014","article-title":"Efficacy and safety of tumor necrosis factor antagonists in Crohn's disease: meta-analysis of placebo-controlled trials","volume":"6","author":"Peyrin-Biroulet","year":"2008","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.clml.2012.09.002_bib20","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1080\/10428190701345433","article-title":"Hepatosplenic T-cell lymphoma in a patient with Crohn's disease who received infliximab therapy","volume":"48","author":"Zeidan","year":"2007","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.clml.2012.09.002_bib21","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1097\/MPG.0b013e31802f6424","article-title":"Hepatosplenic T cell lymphoma associated with infliximab use in young patients treated for inflammatory bowel disease","volume":"44","author":"Mackey","year":"2007","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.clml.2012.09.002_bib22","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1002\/ibd.20169","article-title":"Hepatosplenic T-cell lymphoma in adolescents and young adults with Crohn's disease: a cautionary tale?","volume":"13","author":"Rosh","year":"2007","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.clml.2012.09.002_bib23","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1097\/MPG.0b013e318031d61a","article-title":"Infliximab use and hepatosplenic T cell lymphoma: questions to be asked and lessons learned","volume":"44","author":"Rosh","year":"2007","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.clml.2012.09.002_bib24","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1136\/gut.2004.049460","article-title":"Increased risk of lymphoma among inflammatory bowel disease patients treated with azathioprine and 6-mercaptopurine","volume":"54","author":"Kandiel","year":"2005","journal-title":"Gut"},{"key":"10.1016\/j.clml.2012.09.002_bib25","doi-asserted-by":"crossref","first-page":"4261","DOI":"10.1182\/blood-2003-05-1675","article-title":"Hepatosplenic gammadelta T-cell lymphoma is a rare clinicopathologic entity with poor outcome: report on a series of 21 patients","volume":"102","author":"Belhadj","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.clml.2012.09.002_bib26","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1309\/BM40-YM6J-9T3X-MH8H","article-title":"Hepatosplenic gamma\/delta T-cell lymphoma in bone marrow","volume":"116","author":"Vega","year":"2001","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.clml.2012.09.002_bib27","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1097\/00000478-200103000-00002","article-title":"Hepatosplenic alphabeta T-cell lymphomas: a report of 14 cases and comparison with hepatosplenic gammadelta T-cell lymphomas","volume":"25","author":"Macon","year":"2001","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.clml.2012.09.002_bib28","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1097\/00000478-200003000-00016","article-title":"Hepatosplenic T-cell lymphoma of alphabeta lineage in a 16-year-old boy presenting with hemolytic anemia and thrombocytopenia","volume":"24","author":"Lai","year":"2000","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.clml.2012.09.002_bib29","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1038\/sj.leu.2400742","article-title":"Isochromosome 7q: the primary cytogenetic abnormality in hepatosplenic gammadelta T cell lymphoma","volume":"11","author":"Alonsozana","year":"1997","journal-title":"Leukemia"},{"key":"10.1016\/j.clml.2012.09.002_bib30","first-page":"1453","article-title":"Isochromosome 7q and trisomy 8 are consistent primary, non-random chromosomal abnormalities associated with hepatosplenic T gamma\/delta lymphoma","volume":"10","author":"Jonveaux","year":"1996","journal-title":"Leukemia"},{"key":"10.1016\/j.clml.2012.09.002_bib31","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1097\/00043426-200202000-00020","article-title":"Hepatosplenic gamma\/delta T-cell lymphoma with isochromosome 7q, translocation t(7;21), and tetrasomy 8 in a 9-year-old girl","volume":"24","author":"Rossbach","year":"2002","journal-title":"J Pediatr Hematol Oncol"},{"key":"10.1016\/j.clml.2012.09.002_bib32","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1002\/gcc.10021","article-title":"Fluorescence in situ hybridization study of chromosome 7 aberrations in hepatosplenic T-cell lymphoma: isochromosome 7q as a common abnormality accumulating in forms with features of cytologic progression","volume":"33","author":"Wlodarska","year":"2002","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.clml.2012.09.002_bib33","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1093\/annonc\/mdn751","article-title":"Hepatosplenic gamma-delta T-cell lymphoma: clinicopathological features and treatment","volume":"20","author":"Falchook","year":"2009","journal-title":"Ann Oncol"},{"key":"10.1016\/j.clml.2012.09.002_bib34","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1093\/annonc\/mdn119","article-title":"Hepatosplenic gammadelta T-cell lymphoma successfully treated with a combination of alemtuzumab and cladribine","volume":"19","author":"Jaeger","year":"2008","journal-title":"Ann Oncol"},{"key":"10.1016\/j.clml.2012.09.002_bib35","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1002\/ajh.21062","article-title":"Post-transplant hepatosplenic T-cell lymphoma successfully treated with HyperCVAD regimen","volume":"83","author":"Tey","year":"2008","journal-title":"Am J Hematol"},{"key":"10.1016\/j.clml.2012.09.002_bib36","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1111\/j.1600-0609.2006.00646.x","article-title":"A case of hepatosplenic gamma-delta T-cell lymphoma with a transient response to fludarabine and alemtuzumab","volume":"76","author":"Mittal","year":"2006","journal-title":"Eur J Haematol Jun"},{"key":"10.1016\/j.clml.2012.09.002_bib37","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1080\/10428190500293321","article-title":"Gamma-delta hepatosplenic T-cell lymphoma","volume":"47","author":"Moleti","year":"2006","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.clml.2012.09.002_bib38","first-page":"ECR14","article-title":"Pentostatin (2'-deoxycoformycin) for the treatment of hepatosplenic gammadelta T-cell lymphomas","volume":"90","author":"Corazzelli","year":"2005","journal-title":"Haematologica"},{"key":"10.1016\/j.clml.2012.09.002_bib39","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1046\/j.1365-2141.2002.03537_3.x","article-title":"Hepatosplenic gammadelta T-cell lymphoma: complete response induced by treatment with pentostatin","volume":"117","author":"Iannitto","year":"2002","journal-title":"Br J Haematol"},{"key":"10.1016\/j.clml.2012.09.002_bib40","first-page":"E25","article-title":"Successful allogeneic bone marrow transplantation for hepatosplenic gammadelta T cell lymphoma","volume":"86","author":"Ooi","year":"2001","journal-title":"Haematologica"},{"key":"10.1016\/j.clml.2012.09.002_bib41","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1002\/ajh.10466","article-title":"Hepatosplenic gammadelta T-cell lymphoma in a 10-year-old boy successfully treated with hematopoietic stem cell transplantation","volume":"75","author":"Gassas","year":"2004","journal-title":"Am J Hematol"},{"key":"10.1016\/j.clml.2012.09.002_bib42","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1097\/01.mph.0000187431.37369.f5","article-title":"Allogeneic bone marrow transplantation for chemotherapy-refractory hepatosplenic gammadelta T-cell lymphoma: case report and review of the literature","volume":"27","author":"Domm","year":"2005","journal-title":"J Pediatr Hematol Oncol"},{"key":"10.1016\/j.clml.2012.09.002_bib43","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1038\/sj.bmt.1705272","article-title":"Long-term remission in a patient with hepatosplenic gammadelta T cell lymphoma after cord blood stem cell transplantation following autologous peripheral blood stem cell transplantation","volume":"37","author":"Sakai","year":"2006","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.clml.2012.09.002_bib44","doi-asserted-by":"crossref","first-page":"275","DOI":"10.5507\/bp.2005.040","article-title":"T-cell gamma\/delta hepatosplenic lymphoma - prolonged remission induced by aggressive first line treatment","volume":"149","author":"Proch\u00e1zka","year":"2005","journal-title":"Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub"},{"key":"10.1016\/j.clml.2012.09.002_bib45","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1080\/10428190701400071","article-title":"Graft-versus-lymphoma effect in progressive hepatosplenic gamma\/delta T-cell lymphoma","volume":"48","author":"He","year":"2007","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.clml.2012.09.002_bib46","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/j.bbmt.2008.04.004","article-title":"Long-term results of autologous hematopoietic cell transplantation for peripheral T cell lymphoma: the Stanford experience","volume":"14","author":"Chen","year":"2008","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.clml.2012.09.002_bib47","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1080\/10428190601126941","article-title":"Allogeneic stem cell transplantation for hepatosplenic gammadelta T-cell lymphoma","volume":"48","author":"Konuma","year":"2007","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.clml.2012.09.002_bib48","doi-asserted-by":"crossref","first-page":"2296","DOI":"10.1200\/JCO.1997.15.6.2296","article-title":"Predictive capacity of the international prognostic factor index in patients with peripheral T-cell lymphoma","volume":"15","author":"Ansell","year":"1997","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clml.2012.09.002_bib49","doi-asserted-by":"crossref","first-page":"2474","DOI":"10.1182\/blood-2003-09-3080","article-title":"Peripheral T-cell lymphoma unspecified (PTCL-U): a new prognostic model from a retrospective multicentric clinical study","volume":"103","author":"Gallamini","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.clml.2012.09.002_bib51","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1586\/ehm.09.62","article-title":"Hepatosplenic T-cell lymphoma and TNF-alpha inhibitors","volume":"2","author":"Pozadzides","year":"2009","journal-title":"Expert Rev Hematol"},{"key":"10.1016\/j.clml.2012.09.002_bib52","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1016\/S0140-6736(94)92150-4","article-title":"Long-term neoplasia risk after azathioprine treatment in inflammatory bowel disease","volume":"343","author":"Connell","year":"1994","journal-title":"Lancet"},{"key":"10.1016\/j.clml.2012.09.002_bib53","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1136\/gut.47.4.514","article-title":"Increased incidence of non-Hodgkin's lymphoma in inflammatory bowel disease patients on immunosuppressive therapy but overall risk is low","volume":"47","author":"Farrell","year":"2000","journal-title":"Gut"},{"key":"10.1016\/j.clml.2012.09.002_bib54","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1002\/ibd.20211","article-title":"Lymphoma risk in inflammatory bowel disease: is it the disease or its treatment?","volume":"13","author":"Jones","year":"2007","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.clml.2012.09.002_bib55","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1002\/art.21675","article-title":"Association of chronic inflammation, not its treatment, with increased lymphoma risk in rheumatoid arthritis","volume":"54","author":"Baecklund","year":"2006","journal-title":"Arthritis Rheum"}],"container-title":["Clinical Lymphoma Myeloma and Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2152265012001620?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2152265012001620?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T00:23:21Z","timestamp":1761870201000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2152265012001620"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,2]]},"references-count":54,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,2]]}},"alternative-id":["S2152265012001620"],"URL":"https:\/\/doi.org\/10.1016\/j.clml.2012.09.002","relation":{},"ISSN":["2152-2650"],"issn-type":[{"value":"2152-2650","type":"print"}],"subject":[],"published":{"date-parts":[[2013,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Intensive Induction Chemotherapy Followed by Early High-Dose Therapy and Hematopoietic Stem Cell Transplantation Results in Improved Outcome for Patients with Hepatosplenic T-Cell Lymphoma: A Single Institution Experience","name":"articletitle","label":"Article Title"},{"value":"Clinical Lymphoma Myeloma and Leukemia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clml.2012.09.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Inc.","name":"copyright","label":"Copyright"}]}}